MedTrace Logo

EGFR Molecular Classification In Vivo

NCT03031522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2020-02-21

No results posted yet for this study

Summary

The investigators developed 18F-IRS as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Conditions

  • Molecular Imaging

Interventions

RADIATION

18F-IRS

According to experiment, 18F-IRS was non-toxic and stable in serum.

Sponsors & Collaborators

  • Harbin Medical University

    lead OTHER

Principal Investigators

  • Baozhong Shen, M.D. · The Fourth Hospital of Harbin Medical University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03031522 on ClinicalTrials.gov